PRIMECAP Management trim Eli Lilly and Company Common Stock
PRIMECAP Management trim $8.2B of disclosed value in Eli Lilly and Company Common Stock.
Signal
Investor Move
Action
Trim
Capital
$8.2B disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.